Skip to main content

Table 1

From: Evolution of resistance in Acinetobacter baumannii in a Tunisian intensive care unit after antibiotherapy restriction

% of resistance

2001 (n = 134)

2003 (n = 50)

P

2004 (n = 63)

P'

Ticarcilline

76

63

0.05*

77

0.8

Piperacilline

97

85

0.01*

81

10-3*

Ceftazidim

95

84

0.01*

79

8 × 10-4*

Carbapenem

37

37

0.36

25

0.09

Amikacine

85

70

0.28

68

6 × 10-3*

Netilmycine

30

31

0.86

31

0.7

Ofloxacine

95

87

0.04*

93

0.9

Ciprofloxacine

95

87

0.16

94

0.9

  1. P, 2003 – 2001; P', 2004 – 2001. *P < 0.05.
Back to article page

Critical Care

ISSN: 1364-8535